Health Examination Surveys and Human Biomonitoring – the added value of combined studies

Namorado, Sónia

Publication

Health Examination Surveys and Human Biomonitoring – the added value of combined studies

2018-05-11Conference object

dc.contributor.author	Namorado, Sónia
dc.date.accessioned	2018-05-17T14:41:18Z
dc.date.available	2018-05-17T14:41:18Z
dc.date.issued	2018-05-11
dc.description.abstract	Health Examination Surveys (HES) are health surveys where information collected by questionnaire is complemented with information obtained through physical measurements, such as blood pressure and anthropometric measurements, and through clinical analysis of biological samples. Between 2000 and 2017, 15 European countries have conducted a national HES and in many countries smaller, regional or disease specific surveys have been carried out. Portugal is one of the countries that has recently conducted a first National Health Examination Survey (INSEF), which collected interview and anthropometric data and blood samples in a nationally representative sample of 4911 individuals aged between 25 and 74 years old. Human Biomonitoring (HBM) is a scientific approach used to assess individual human exposure to environmental chemicals by measuring substances, their metabolites or reaction products in biological specimens. Many countries have established HBM programs to monitor the chemical exposures of their populations. HES and HBM studies are very similar in terms of the infrastructure and procedures necessary for their implementation, as in either type of studies data is collected through fieldwork, which constitutes one of the largest expenditures for such studies. Combined studies could then result in more costeffective ways to conduct health and environmental monitoring. Some countries, like the USA, Canada, Germany, Belgium and France have already recognized the potential to combine these two types of studies and have successfully implemented surveys with both components. However, in practice, the opportunity for adding an HBM module to a health study and vice versa is rarely used. Reasons for this may be multifarious and may differ from country to country, and between different study settings. Within the HBM4EU project the advantages and obstacles of combined studies are being evaluated and feasibility studies will be conducted in order to identify practical/logistic, financial and scientific benefits and short comings.	pt_PT
dc.description.sponsorship	No âmbito do projeto HBM4EU, da qual fazem parte a Fundação para a Ciência e Tecnologia, I.P. (FCT), o Instituto Nacional de Saúde Dr. Ricardo Jorge, I.P. (INSA), a Direção Geral de Saúde (DGS) e a Agência Portuguesa do Ambiente, I.P. (APA), em parceria com a Faculdade de Medicina, Universidade de Lisboa (FMUL) e a Escola Superior de Tecnologia da Saúde Lisboa (ESTeSL), Instituto Politécnico de Lisboa.	pt_PT
dc.description.version	N/A	pt_PT
dc.identifier.uri	http://hdl.handle.net/10400.18/5558
dc.language.iso	eng	pt_PT
dc.peerreviewed	no	pt_PT
dc.publisher	Instituto Nacional de Saúde Doutor Ricardo Jorge, IP	pt_PT
dc.relation	European Human Biomonitoring Initiative
dc.rights.uri	http://creativecommons.org/licenses/by-nc/4.0/	pt_PT
dc.subject	Biomonitorização humana	pt_PT
dc.subject	Determinantes da Saúde e da Doença	pt_PT
dc.subject	Human Biomonitoring	pt_PT
dc.subject	Health Examination Surveys	pt_PT
dc.subject	Chemical Exposure	pt_PT
dc.subject	Human Health	pt_PT
dc.title	Health Examination Surveys and Human Biomonitoring – the added value of combined studies	pt_PT
dc.type	conference object
dspace.entity.type	Publication
oaire.awardTitle	European Human Biomonitoring Initiative
oaire.awardURI	info:eu-repo/grantAgreement/EC/H2020/733032/EU
oaire.citation.conferencePlace	Lisboa, Portugal	pt_PT
oaire.citation.title	1st Human Biomonitoring Workshop in Portugal “Bridging Chemical Exposure to Human Health”, INSA, 11 maio 2018	pt_PT
oaire.fundingStream	H2020
project.funder.identifier	http://doi.org/10.13039/501100008530
project.funder.name	European Commission
rcaap.rights	openAccess	pt_PT
rcaap.type	conferenceObject	pt_PT
relation.isProjectOfPublication	6815dc2d-ef7e-4535-8dd3-5193c8bffba5
relation.isProjectOfPublication.latestForDiscovery	6815dc2d-ef7e-4535-8dd3-5193c8bffba5